Investor Alert

Perrigo Co. PLC



After Hours

 --Quotes are delayed by 20 min

Dec 6, 2021, 5:29 p.m.





0.00 0.00%


Volume 32,098

Quotes are delayed by 20 min


Today's close

$ 35.79

$ 37.04


+1.25 +3.49%

Day low

Day high




52 week low

52 week high




Jeffrey B. Kindler

Founder of Centrexion Therapeutics Corp., Jeffrey B. Kindler is a businessperson who has been the head of 8 different companies and holds the position of Chairman at GLG Healthcare Institute, Chief Executive Officer & Director at Centrexion Therapeutics Corp., Venture Partner at Lux Capital Group LLC and Chairman at vTv Therapeutics LLC. Mr. Kindler is also Director at Starboard Capital Partners LLC, Member of The U.S.-Japan Business Council, Inc., Principal at Paragon Pharmaceuticals Capital LLC and Principal at Marathon Pharmaceuticals LLC and on the board of 14 other companies.

In the past Mr. Kindler held the position of Chairman & Chief Executive Officer at Pfizer Inc., Chairman at vTv Therapeutics, Inc., Partner at Williams & Connolly LLP, Trustee at The Business Roundtable, Trustee at The Business Council, Editor at The Harvard Law Review Association, Executive VP-Corporate Relations & General Counsel at McDonald's Corp. and President at Partner Brands (a subsidiary of McDonald's Corp.), Vice President-Litigation & Legal Policy at General Electric Co., Chairman of Boston Market Corp., Chairman for Pharmaceutical Research & Manufacturers of America, Trustee at Ronald McDonald House Charities, Inc., Director at Lincoln Center for the Performing Arts, Inc. and Director at Manhattan Theatre Club, Inc.

He received an undergraduate degree from Tufts University and a graduate degree from Harvard Law School.


Date Shares Transaction Value
05/07/2021 2,786   Derivative/Non-derivative trans. at $42.96 per share. 119,687
05/07/2021 5,804   Derivative/Non-derivative trans. at $42.96 per share. 249,339
05/15/2020 2,906   Derivative/Non-derivative trans. at $52.76 per share. 153,321
05/15/2020 6,054   Derivative/Non-derivative trans. at $52.76 per share. 319,409
05/15/2019 1,907   Derivative/Non-derivative trans. at $49.55 per share. 94,492
05/15/2019 3,971   Derivative/Non-derivative trans. at $49.55 per share. 196,763
06/06/2018 2,048   Derivative/Non-derivative trans. at $73.22 per share. 149,955
06/06/2018 4,265   Derivative/Non-derivative trans. at $73.22 per share. 312,283
07/20/2017 489   Derivative/Non-derivative trans. at $75.51 per share. 36,925
07/20/2017 1,017   Derivative/Non-derivative trans. at $75.51 per share. 76,793

Officers and Executives

Mr. Murray S. Kessler
President, Chief Executive Officer & Director
Mr. Raymond P. Silcock
CFO, Principal Accounting Officer & Executive VP
Mr. Thomas M. Farrington
Chief Information Officer & Executive VP
Dr. Grainne Quinn
Chief Medical Officer & Executive Vice President
Mr. Adrian Innergård
General Manager-Northern Europe
Ms. Sharon Kochan
EVP, President-RX Pharmaceuticals
Mr. Svend D. Andersen
EVP & President-Consumer Selfcare International
Mr. Ronald C. Janish
Chief Transformation Officer
Mr. James E. Dillard
President-CSCA & Executive Vice President
Mr. Louis K. Cherico
Treasurer & Vice President
Mr. Bradley Joseph
Vice President-Global Investor Relations
Mr. Robert Willis
Chief Human Resources Officer & Executive VP
Mr. Todd W. Kingma
Secretary, Executive VP & General Counsel
Mr. Rolf Allan Classon
Ms. Katherine C. Doyle
Independent Director
Mr. Orlando D. Ashford
Independent Director
Mr. Donal M. O'Connor
Independent Director
Mr. Geoffrey M. Parker
Independent Director
Mr. Theodore Rapp Samuels
Independent Director
Mr. Bradley A. Alford
Independent, Director
Mr. Jeffrey B. Kindler
Independent Director
Ms. Adriana Karaboutis
Independent Director
Ms. Erica L. Mann
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
Powered by StockTwits
Link to MarketWatch's Slice.